Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14051 - 14075 of 14352 in total
Experimental
Posizolid (AZD2563) is an oxazolidinone antibiotic. In July 2002, after completion of phase I trials in December 2001, AstraZeneca announced that they were no longer pursuing the development of Posizolid, presumably due to negative trial results (though no results were reported).
Investigational
Investigational
Experimental
Displaying drugs 14051 - 14075 of 14352 in total